CYP3A4 and breast cancer: Indeed, docetaxel and paclitaxel both undergo liver metabolism through CYP3A4; therefore, if curcumin had inhibited this isozyme, one would have expected a potentiation of taxane anticancer effects in metastatic prostate and breast cancer patients but unfortunately, this has not occurred [30,31,40].